Portal de investigación
Versatile Polypeptide-based Intranasal Drug Delivery Platform(s) to Tackle CNS Disorders. ERC. POLYBRAINT
Datos básicos
- Código Financiador:
- Año inicial:
- 2022
- Año final:
- 2023
Documentos
- No hay documentos
Participantes
Grupos de Investigación
Financiadores
COMMISSION OF EUROPEAN COMMUNITIES
Resultados del Proyecto
A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models.
Andreu Z; (...); Vicent MJ
Article. 10.7150/ntno.73606. 2023
An Offset Patterned Cross-ß Structure in Assemblies of C 3 -Symmetric Peptide Amphiphiles.
Zagorodko O; (...); Vicent MJ
Article. 10.1002/chem.202303194. 2024
Critical Design Strategies Supporting Optimized Drug Release from Polymer-Drug Conjugates.
Ðordevic S; (...); Vicent MJ
Article. 10.1002/smll.202303157. 2023
NMR-Based Mitochondria Metabolomic Profiling: A New Approach To Reveal Cancer-Associated Alterations.
Domingo-Ortí I; (...); Palomino-Schätzlein M
Article. 10.1021/acs.analchem.3c02432. 2023
Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer.
Vicente-Ruiz S; (...); Vicent MJ
Article. 10.1016/j.biomaterials.2023.122280. 2023
Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment.
Melnyk T; (...); Vicent MJ
Article. 10.1016/j.jconrel.2023.01.079. 2023
Transplantation of Human-Fetal-Spinal-Cord-Derived NPCs Primed with a Polyglutamate-Conjugated Rho/Rock Inhibitor in Acute Spinal Cord Injury.
Giraldo E; (...); Moreno Manzano V
Article. 10.3390/cells11203304. 2022